Ignite Creation Date:
2024-10-25 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06507839
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Study to Assess the Safety Tolerability Pharmacokinetic of Thrv-1268
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A First-in-Human Randomized Double-Blind Placebo-Controlled Single and Multiple Ascending Dose Study To Assess the Safety Tolerability Pharmacokinetics and Food Effect of Thrv-1268 in Healthy Adult Subjects
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center randomized double-blind placebo-controlled study to be conducted in 2 parts single ascending dose SAD incorporating a food effect arm and multiple ascending dose MAD Potential participants for each part will undergo screening procedures within 28 days of enrollment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None